Becton Dickinson announces FDA Emergency Use Authorization for new COVID-19 diagnostic for use in U.S.

Becton Dickinson, a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen for COVID-19 (coronavirus) on site and get results in...
Read More...

FDA Awards $914,600 Contract to Morgan State University to Optimize the Quality of Botanical Drug Products

A recent research award of $914,600 from the U.S. Food and Drug Administration’s (FDA’s), Center for Drug Evaluation and Research, Office of Pharmaceutical Quality (OPQ) has put Morgan State University in a prime position to explore the approaches to address the quality of botanical drug products. The two-year research contract...
Read More...